查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786784

抗体受託製造的全球市场，规模，占有率，趋势，产业分析报告:各产品，来历，各治疗领域，各终端用户，各地区 - 市场预测，2025年～2034年

Antibody Contract Manufacturing Market Size, Share, & Industry Analysis Report By Product, By Product (Monoclonal Antibodies, Polyclonal Antibodies), By Source, By Therapeutic Area, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，抗体合约製造市场规模将达到 449.6 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

抗体合约製造使生物製药公司能够透过外包单株抗体、多克隆抗体和双特异性抗体的生产来满足日益增长的治疗和诊断需求。这些服务在严格的监管和品质准则下进行，以确保高产量、产品一致性和临床级安全性。

全球癌症和其他慢性疾病的发生率不断上升，推动了市场成长，这推动了对基于抗体的标靶治疗的需求。全球肿瘤学和免疫学研发支出的不断增长，进一步支持了下一代生物製剂的开发。

抗体合约生产市场报告重点

按产品划分，单株抗体预计将在2024年占最大的市场占有率，这得益于需要长期免疫抑制治疗的肾臟、肝臟和心臟移植手术数量的增加。

按来源划分，哺乳动物抗体由于其与复杂蛋白质结构的高度相容性以及能够产生对治疗效果至关重要的糖基化谱的能力而占市场主导地位。

依治疗领域划分，传染病领域预计将成长最快，这得益于对抗新兴病毒和慢性传染病的抗体疗法需求不断增长。

按最终用户划分，预计生物製药公司将在2024年占绝对占有率，这得益于将抗体生产外包给专业合约生产组织(CMO)以优化成本和快速商业化的趋势日益增长。

2024年，北美在全球抗体合约製造市场占主导地位，这得益于其强大的生物製药製造能力以及先进生物製剂快速融入生产流程。

由于生物技术产业的显着增长以及与国际製药公司的合作和外包协议的增加，亚太地区经历了稳步增长。

全球主要市场参与者包括龙沙集团、三星生物製品、药明生物、勃林格殷格翰国际有限公司、富士迪奥辛斯生物技术公司、康泰伦特公司、艾伯维公司、赛默飞世尔科技公司、Shilpa Medicare 有限公司、乐天生物製品、默克集团和查尔斯河实验室。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球抗体受託製造市场洞察

  • 市场概述
  • 抗体受託製造市场动态
    • 促进因素和机会
      • 全球癌症病例不断增加
      • 全球研发支出不断增加
    • 限制与课题
      • 高昂的製造成本和复杂的法规合规性
  • PESTEL分析
  • 抗体受託製造市场趋势
  • 价值链分析

第5章 全球抗体受託製造市场:各产品

  • 主要调查结果
  • 简介
  • 单株抗体
  • 多株抗体
  • 双特异性抗体
  • 其他

第6章 全球抗体受託製造市场:来历

  • 主要调查结果
  • 简介
  • 哺乳类
  • 微生物

第7章 全球抗体受託製造市场:各治疗领域

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 神经学
  • 心臟病
  • 感染疾病
  • 其他

第8章 全球抗体受託製造市场:各终端用户

  • 主要调查结果
  • 简介
  • 生物医药品企业
  • 研究所
  • 其他

第9章 全球抗体受託製造市场:各地区

  • 主要调查结果
  • 简介
    • 抗体受託製造市场评估:各地区，2020-2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各:来历，2020～2034年
    • 北美:各治疗领域，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各来历，2020～2034年
    • 欧洲:各治疗领域，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各来历，2020～2034年
    • 亚太地区:各治疗领域，2020年～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各来历，2020～2034年
    • 中东·非洲:各治疗领域，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各来历，2020～2034年
    • 南美:各治疗领域，2020-2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Charles River Laboratories
  • Fujifilm Diosynth Biotechnologies
  • Lonza Group AG
  • Lotte Biologics
  • Merck Group
  • Samsung Biologics
  • Shilpa Medicare Ltd.
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics
Product Code: PM6086

The antibody contract manufacturing market size is expected to reach USD 44.96 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Product (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Others), By Source, By Therapeutic Area, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody contract manufacturing involves the outsourced production of monoclonal antibodies, polyclonal, and bispecific antibodies, enabling biopharmaceutical companies to meet growing therapeutic and diagnostic demands. These services are executed under stringent regulatory and quality guidelines to ensure high yield, product consistency and clinical-grade safety.

The market growth is fueled by the increasing global incidence of cancer and other chronic diseases, which is driving demand for targeted antibody-based therapies. Rising global R&D expenditure in oncology and immunology is further boosting the development of next-generation biologics.

Antibody Contract Manufacturing Market Report Highlights

Based on product, the monoclonal antibodies segment accounted for the largest market share in 2024, due to the rising number of kidney, liver, and heart transplant surgeries requiring long-term immunosuppressive therapy.

Based on source, the mammalian segment dominated the market, driven by its high compatibility with complex protein structures and ability to produce glycosylation profiles essential for therapeutic efficacy.

Based on therapeutic area, the infectious diseases segment is expected to witness the fastest growth, fueled by increasing demand for antibody-based therapies to combat emerging viral infections and rising prevalence of chronic infectious conditions.

Based on end user, the biopharmaceutical companies segment held the dominant share in 2024, due to the growing trend of outsourcing antibody production to specialized CMOs for cost optimization and faster commercialization.

North America dominated the global antibody contract manufacturing market in 2024, fueled by robust biopharmaceutical manufacturing capacity and the rapid integration of advanced biologics into production processes.

Asia Pacific witnessed a steady growth, due to significant growth in the regional biotechnology industry, coupled with rising collaborations and outsourcing agreements with international pharmaceutical companies.

A few global key market players include Lonza Group AG, Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies, Catalent, Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Shilpa Medicare Ltd., Lotte Biologics, Merck Group, and Charles River Laboratories.

Polaris Market Research has segmented the market report on the basis of product, source, therapeutic area, end user, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibodies

Polyclonal Antibodies

Bispecific Antibodies

Others

By Source Outlook (Revenue, USD Billion, 2020-2034)

Mammalian

Microbial

By Therapeutic Area (Revenue, USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Infectious Diseases

Other Therapeutic Areas

By End User (Revenue, USD Billion, 2020-2034)

Biopharmaceutical Companies

Research Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antibody Contract Manufacturing Market Insights

  • 4.1. Antibody Contract Manufacturing Market - Market Snapshot
  • 4.2. Antibody Contract Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Cases of Cancer Worldwide
      • 4.2.1.2. Rising Global R&D Expenditure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Manufacturing Cost and Complex Regulatory Compliance
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibody Contract Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global Antibody Contract Manufacturing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Monoclonal Antibodies
    • 5.3.1. Global Antibody Contract Manufacturing Market, by Monoclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.4. Polyclonal Antibodies
    • 5.4.1. Global Antibody Contract Manufacturing Market, by Polyclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.5. Bispecific Antibodies
    • 5.5.1. Global Antibody Contract Manufacturing Market, by Bispecific Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Antibody Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Antibody Contract Manufacturing Market, by Source

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 6.3. Mammalian
    • 6.3.1. Global Antibody Contract Manufacturing Market, by Mammalian, by Region, 2020-2034 (USD Billion)
  • 6.4. Microbial
    • 6.4.1. Global Antibody Contract Manufacturing Market, by Microbial, by Region, 2020-2034 (USD Billion)

7. Global Antibody Contract Manufacturing Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Antibody Contract Manufacturing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Neurology
    • 7.4.1. Global Antibody Contract Manufacturing Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 7.5. Cardiology
    • 7.5.1. Global Antibody Contract Manufacturing Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Antibody Contract Manufacturing Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 7.7. Other Therapeutic Areas
    • 7.7.1. Global Antibody Contract Manufacturing Market, by Other Therapeutic Areas, by Region, 2020-2034 (USD Billion)

8. Global Antibody Contract Manufacturing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Biopharmaceutical Companies
    • 8.3.1. Global Antibody Contract Manufacturing Market, by Biopharmaceutical Companies by Region, 2020-2034 (USD Billion)
  • 8.4. Research Laboratories
    • 8.4.1. Global Antibody Contract Manufacturing Market, by Research Laboratories, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Antibody Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Antibody Contract Manufacturing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Antibody Contract Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Antibody Contract Manufacturing Market - North America
    • 9.3.1. North America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.3.3. North America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.4. North America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. Antibody Contract Manufacturing Market - U.S.
      • 9.3.5.1. U.S.: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. Antibody Contract Manufacturing Market - Canada
      • 9.3.6.1. Canada: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.4. Antibody Contract Manufacturing Market - Europe
    • 9.4.1. Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. Antibody Contract Manufacturing Market - UK
      • 9.4.5.1. UK: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. Antibody Contract Manufacturing Market - France
      • 9.4.6.1. France: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. Antibody Contract Manufacturing Market - Germany
      • 9.4.7.1. Germany: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. Antibody Contract Manufacturing Market - Italy
      • 9.4.8.1. Italy: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. Antibody Contract Manufacturing Market - Spain
      • 9.4.9.1. Spain: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. Antibody Contract Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. Antibody Contract Manufacturing Market - Russia
      • 9.4.11.1. Russia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. Antibody Contract Manufacturing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.5. Antibody Contract Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. Antibody Contract Manufacturing Market - China
      • 9.5.5.1. China: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. Antibody Contract Manufacturing Market - India
      • 9.5.6.1. India: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. Antibody Contract Manufacturing Market - Malaysia
      • 9.5.7.1. Malaysia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. Antibody Contract Manufacturing Market - Japan
      • 9.5.8.1. Japan: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. Antibody Contract Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. Antibody Contract Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. Antibody Contract Manufacturing Market - Australia
      • 9.5.11.1. Australia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. Antibody Contract Manufacturing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.6. Antibody Contract Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. Antibody Contract Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. Antibody Contract Manufacturing Market - UAE
      • 9.6.6.1. UAE: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. Antibody Contract Manufacturing Market - Israel
      • 9.6.7.1. Israel: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. Antibody Contract Manufacturing Market - South Africa
      • 9.6.8.1. South Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. Antibody Contract Manufacturing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.7. Antibody Contract Manufacturing Market - Latin America
    • 9.7.1. Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. Antibody Contract Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. Antibody Contract Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. Antibody Contract Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. Antibody Contract Manufacturing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AbbVie Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Boehringer Ingelheim International GmbH
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Catalent, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Charles River Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Fujifilm Diosynth Biotechnologies
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Lonza Group AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lotte Biologics
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Merck Group
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Samsung Biologics
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Shilpa Medicare Ltd.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. WuXi Biologics
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 3 Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 4 Global Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 5 North America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 7 North America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 8 North America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 9 U.S.: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 10 U.S.: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 11 U.S.: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 12 U.S.: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Canada: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 15 Canada: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 16 Canada: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 19 Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 20 Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 21 UK: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 22 UK: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 23 UK: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 24 UK: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 25 France: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 26 France: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 27 France: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 28 France: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 29 Germany: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 31 Germany: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 32 Germany: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Italy: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 35 Italy: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 36 Italy: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Spain: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 39 Spain: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 40 Spain: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Russia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 47 Russia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 48 Russia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 57 China: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 58 China: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 59 China: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 60 China: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 61 India: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 62 India: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 63 India: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 64 India: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 69 Japan: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 71 Japan: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 72 Japan: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 77 South Korea: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 79 South Korea: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 80 South Korea: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Australia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 83 Australia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 84 Australia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 97 UAE: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 99 UAE: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 100 UAE: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Israel: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 103 Israel: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 104 Israel: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 105 South Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 107 South Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 108 South Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 113 Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 115 Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 116 Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 117 Mexico: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 119 Mexico: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 120 Mexico: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 121 Brazil: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 123 Brazil: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 124 Brazil: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 125 Argentina: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 127 Argentina: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 128 Argentina: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Antibody Contract Manufacturing Market, by Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Antibody Contract Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Antibody Contract Manufacturing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Antibody Contract Manufacturing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Antibody Contract Manufacturing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Antibody Contract Manufacturing Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Source
  • Figure 9. Global Antibody Contract Manufacturing Market, by Source, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global Antibody Contract Manufacturing Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End User
  • Figure 13. Global Antibody Contract Manufacturing Market, by End User, 2024 & 2034 (USD Billion)